Package Leaflet: Information for the User
Fastum 25 mg/g Gel
Ketoprofen
Read the package leaflet carefully before starting to use this medicine, as it contains important information for you.
Contents of the Package Leaflet
Fastum contains ketoprofen, which is a medicine belonging to the group of non-steroidal anti-inflammatory drugs.
Fastum is indicated for the treatment of painful, inflammatory, or bruised conditions of the joints, tendons, ligaments, and muscles (arthritis, periarthritis, artrosynovitis, tendinitis, tenosynovitis, bursitis, bruises, sprains, dislocations, meniscal injuries of the knee, torticollis, lumbalgia).
Do not use Fastum
Warnings and precautions
Talk to your doctor or pharmacist before starting to use Fastum
Children and adolescents
The safety and efficacy of ketoprofen in children have not been established.
Other medicines and Fastum
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, including those obtained without a prescription.
Tell your doctor if you are taking oral anticoagulants (medicines to prevent blood clot formation).
It is unlikely to interact with other medicines due to its direct application to the skin.
Do not apply other topical preparations to the same area of skin where you are using this medicine.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Do not use ketoprofen if you are in the last 3 months of pregnancy. Do not use ketoprofen during the first 6 months of pregnancy unless clearly necessary and as directed by your doctor. If you need treatment during this period, you should use the minimum dose for the shortest possible time.
Oral formulations (e.g., tablets) may cause adverse effects on the fetus. It is unknown if the same risk applies to ketoprofen via topical route.
There is not enough data on the excretion of ketoprofen in breast milk, so its use is not recommended during breastfeeding.
Driving and using machines
No effects on the ability to drive and use machines have been described.
Fastum contains methylparaben, propylparaben, alcohol (ethanol), and lavender essence.
This medicine may cause allergic reactions (possibly delayed) because it contains methylparaben and propylparaben.
This medicine contains 400 mg of alcohol (ethanol) per gram of gel. It may cause a burning sensation on damaged skin.
This medicine contains lavender essence with benzyl alcohol, amylcinnamaldehyde, citral, eugenol, hydroxycitronellal, coumarin, geraniol, farnesol, linalool, benzyl benzoate, citronellol, and d-limonene, which may cause allergic reactions.
Topical use.
Follow exactly the administration instructions of this medicine as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Fastum is used topically. Apply the gel once or more times a day (3-5 cm or more depending on the extent of the affected area), giving a gentle massage to facilitate absorption.
The total daily dose should not exceed 15 g per day, which is equivalent to 28 cm of skin.
Close the tube of Fastum after each use. Wash your hands after each application.
Your doctor will indicate the duration of your treatment with Fastum.
The duration of continuous treatment with topical ketoprofen should be limited to a maximum of 7 days.
If you think the effect of Fastum is too strong or too weak, tell your doctor or pharmacist.
If you use more Fastum than you should
Due to the topical administration of the medicine, overdose is very unlikely.
In case of accidental ingestion of Fastum, contact your doctor or the emergency department of the nearest hospital immediately.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to use Fastum
If you forget to apply a dose, apply the usual dose as soon as possible, but do not apply a double dose to make up for the forgotten dose.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most common ones are localized cutaneous side effects, which can spread around the application site and are rarely severe and/or generalized.
Side effects can occur with the following frequency:
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Frequency not known (cannot be estimated from the available data):
Elderly patients are more susceptible to the adverse effects of non-steroidal anti-inflammatory drugs, the group to which ketoprofen, the active ingredient of Fastum, belongs.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
No special storage conditions are required.
Do not use this medicine after the expiry date stated on the packaging. The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Fastum
Appearance of the product and package contents
Fastum is a transparent gel. Each package contains 60 grams of gel.
Marketing authorization holder and manufacturer
Laboratorios Menarini, S.A.
Alfons XII, 587
08918 Badalona (Barcelona)
Spain
You can request more information about this medicine by contacting the local representative of the marketing authorization holder
Guidotti Farma, S.L.
Alfons XII, 587
08918 Badalona (Barcelona)
Spain
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) (http://www.aemps.gob.es/)